1. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Shrestha, A.; Penrod, J.R.; Reck, M.; Spigel, D.R.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Healey, D.; Hertel, N.; Korytowsky, B.; Cope, S.; Vanderpuye-Orgle, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Shrestha, A.; Penrod, J.R.; Reck, M.; Spigel, D.R.; Smiechowski, B.; Bognar, K.; van Eijndhoven, E.; Makris, C.; Healey, D.; Hertel, N.; Korytowsky, B.; Cope, S.; Vanderpuye-Orgle, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Eberhardt, W.E.E.; Vanderpuye-Orgle, J.; Reck, M.; Waterhouse, D.; Smiechowski, B.; Bognar, K.; Van Eijndhoven, E.; Makris, C.; Blackwood-Chirchir, A.; Hertel, N.; Korytowsky, B.; Cope, S.; Penrod, J.R.; Shrestha, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs). (February 2017) Authors: Eberhardt, W.E.E.; Vanderpuye-Orgle, J.; Reck, M.; Waterhouse, D.; Smiechowski, B.; Bognar, K.; van Eijndhoven, E.; Makris, C.; Blackwood-Chirchir, A.; Hertel, N.; Korytowsky, B.; Cope, S.; Penrod, J.R.; Shrestha, A. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up. (January 2023) Authors: Chaudhary, M. A.; Edmondson-Jones, M.; Baio, G.; Mackay, E.; Penrod, J. R.; Sharpe, D. J.; Yates, G.; Rafiq, S.; Johannesen, K.; Siddiqui, M. K.; Vanderpuye-Orgle, J.; Briggs, A. Journal: Medical decision making Issue: Volume 43:Number 1(2023) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗